Nieuws

apr
16

Weekly new calls from the National Institutes of Health (NIH) April 12, 2013

The National Institutes of Health's (NIH) mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability. It is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions around the world.

These are the weekly NIH funding opportunities of April 12, 2013:
• Modeling of Infectious Disease Agent Study Information Technology Resource (U24): Letter of Intent Due Date June 18, 2013;
• Eradication of HIV-1 from CNS Reservoirs: Implications for Therapeutics (R01): Letter of Intent Due Date August 17, 2013;
• Eradication of HIV-1 from CNS Reservoirs: Implications for Therapeutics (R21): Letter of Intent Due Date August 17, 2013;
• Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Structural Interventions, Alcohol Use, and Risk of HIV/AIDS (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Mechanisms of Alcohol and Nicotine Co-Addiction (R21): Application Receipt Date(s): Multiple dates, see announcement;
• Mechanisms of Alcohol and Nicotine Co-Addiction (R01): Application Receipt Date(s): Multiple dates, see announcement;
• Revision Applications to R01 Awards for Research on Detection of Pathogen-Induced Cancer (DPIC) (R01): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) July 10, 2013; December 11, 2013; July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015, by 5:00 PM local time of applicant organization;
• Revision Applications to U01 Awards on Detection of Pathogen-Induced Cancer (DPIC) (U01): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) July 10, 2013; December 11, 2013; July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015, by 5:00 PM local time of applicant organization;
• Revision Applications to U01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (U01): Letter of Intent Due Date(s) 30 days before the due date. Application Due Date(s) July 10, 2013; December 11, 2013; July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015, by 5:00 PM local time of applicant organization;
• Revision Applications to R01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (R01): Letter of Intent Due Date(s) 30 days before the due date. Application Due Date(s) July 10, 2013, December 11, 2013, July 10, 2014, December 11, 2014, July 10, 2015, December 11, 2015, by 5:00 PM local time of applicant organization;
• Collaborative Research in Integrative Cancer Biology (U01): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) June 18, 2013; November 13, 2013; June 18, 2014; November 13, 2014; June 18, 2015; November 13, 2015, by 5:00 PM local time of applicant organization;
• Image-guided Drug Delivery in Cancer (R01): Application Due Date(s) June 19, 2013; November 19, 2013; June 19, 2014; November 19, 2014; June 19, 2015; November 19, 2015, by 5:00 PM local time of applicant organization;
• Imaging and Biomarkers for Early Cancer Detection (R01): Letter of Intent Due Date(s) 30 days before the due date. Application Due Date(s) July 10, 2013, December 11, 2013, July 10, 2014, December 11, 2014, July 10, 2015, December 11, 2015, by 5:00 PM local time of applicant organization;
• Detection of Pathogen-Induced Cancer (DPIC) (R01): Letter of Intent Due Date(s) 30 days before the application due date. Application Due Date(s) July 10, 2013; December 11, 2013; July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015, by 5:00 PM local time of applicant organization.

For more active Requests for Applications (RFAs) and Program Announcements (PAs) please click here.

Terug naar overzicht